博晖创新(300318.SZ)：与控股股东签订《股权托管协议》

Group 1 - The core point of the article is that the controlling shareholder of BoHui Innovation (300318.SZ) has signed a share transfer agreement to acquire 14.7001% of the equity in Hebei BoHui Biopharmaceutical Co., Ltd. from Tongying Group [1] - To maintain the company's independence and avoid potential competition, the controlling shareholder plans to sign a share custody agreement with the company, entrusting the management of the acquired shares to the company without charge [1] - The share custody agreement has been reviewed by the independent directors and approved by the company's board of directors, resulting in a total of 15.4216% of Hebei BoHui's shares being managed by the company [1]